Skip to main content
Edition No. 104 · GlobalEst. 2026
S&P 5007,340.53-2.40%Dow Jones50,759.42-2.82%Nasdaq24,328.38-2.94%FTSE 10010,689.87-0.57%DAX26,045.37-1.15%Nikkei 22558,860.43-3.22%Hang Seng23,508.17-4.27%EUR/USD1.0988-0.96%GBP/USD1.3199-0.59%Gold3,852.90-0.83%Crude Oil85.86-3.25%Bitcoin64,810.36+1.06%S&P 5007,340.53-2.40%Dow Jones50,759.42-2.82%Nasdaq24,328.38-2.94%FTSE 10010,689.87-0.57%DAX26,045.37-1.15%Nikkei 22558,860.43-3.22%Hang Seng23,508.17-4.27%EUR/USD1.0988-0.96%GBP/USD1.3199-0.59%Gold3,852.90-0.83%Crude Oil85.86-3.25%Bitcoin64,810.36+1.06%

New Clinical Trials Confirm Efficacy of Bilateral Hypoglossal Nerve Stimulation for Sleep Apnea

Innovative dual-sided nerve stimulation technology shows promise for patients unable to tolerate traditional CPAP therapy.

By Planet Earth News Health & Fitness Desk· Published 2026-10-13· 2 min read
PENN Explainer

Hear this story explained in 90 seconds.

A recent nonrandomized clinical trial has provided new evidence regarding the effectiveness of bilateral hypoglossal nerve stimulation for treating obstructive sleep apnea. The study, published in the Journal of Clinical Sleep Medicine, evaluated a novel device designed to stimulate nerves on both sides of the airway. This approach aims to improve sleep quality for patients who struggle with standard continuous positive airway pressure, or CPAP, machines. Obstructive sleep apnea is a common condition where breathing repeatedly stops and starts during sleep, often leading to severe daytime fatigue and long-term health risks. Researchers involved in the trial, including B. Tucker Woodson, noted that the device demonstrated an acceptable safety profile throughout the study period. Participants experienced clinically significant improvements in both the severity of their sleep apnea and their overall quality of life. The trial, registered as the DREAM study, highlights the growing interest in surgical and electrical alternatives for those who cannot use traditional masks. Hypoglossal nerve stimulation works by activating the muscles of the upper airway, specifically the genioglossus muscle, to keep the airway open during sleep. By preventing the collapse of these tissues, the device helps maintain consistent breathing patterns throughout the night. This mechanism of action has been the subject of increasing research as medical professionals seek more personalized treatment options. Recent secondary analyses of earlier trials have also shown that this form of stimulation can reduce the hypoxic burden, which refers to the cumulative impact of low oxygen levels on the body during sleep. Reducing this burden is considered a critical factor in mitigating the cardiovascular risks associated with untreated apnea. While CPAP remains the standard of care, these findings suggest that nerve stimulation is becoming a viable alternative for a broader spectrum of patients. The research indicates that success rates can vary based on individual patient characteristics, such as body mass index and sleep architecture. Future studies are expected to further refine which patients are the best candidates for these implantable systems. As technology advances, the medical community continues to explore how targeted stimulation can be optimized to improve patient outcomes. The ongoing development of these devices represents a significant step forward in the field of sleep medicine and public health.

You've reached your free article limit

You've read 10 of 10 free articles this month. Subscribe to Planet Earth News Network for unlimited access to neutral, global journalism — plus puzzles, podcasts, and the weekly newsletter.

Already a subscriber? Sign in.

Ask the Author

Subscribers can ask the journalist a question about this story. Subscribe to ask.

Neutrality note

Auto-harvested from global news wires and presented neutrally by PENN.

Share this article

to vote

Comments

No comments yet — be the first to share your thoughts.

Related stories in Health and Fitness